To investigate the role of HMGB1 in SC dedifferentiation and its impact on tumor progression, we introduced glycyrrhizin (1 nM) to inhibit HMGB1 expression in subsequent protein immunoblotting and IF experiments [55]. The gene discussed is HMGB1; the disease is neoplasm.